Section A: General consideration on cancer nanomedicines 1. Nanomedicine for combinational anticancer drug therapeutics: Recent advances, challenges and future perspectives 2. Market research in cancer therapeutics: New and Generic Product Development 3. Regulatory perspectives of nanomedicines for cancer treatment
Section B: Formulation technologies in cancer nanomedicines 4. Biopharmaceutical challenges in using lipid nanoparticles for oral chemotherapy 5. Polymeric nanoparticles for potential drug delivery applications in cancer 6. Lipid-polymer hybrid nanoparticles: Production, characterization and formulation of nucleic acids for cancer therapy 7. Metallic nanoparticles in drug delivery and cancer treatment 8. Liposomal nanotherapeutics in cancer treatment 9. Surface decoration strategies in nanomedicines for cancer treatment 10. Protein based nanomedicines as anticancer drug delivery platform 11. Phyto actives loaded nanocarriers for liver cancer treatment
Section C: Innovative treatment strategies in cancer nanomedicines 12. Nanotechnology assisted medical devices in cancer treatment 13. Immunotherapy as a boon in cancer treatment 14. Antibody-drug combination therapy in cancer treatment 15. Immune-chemo combination therapy in cancer treatment
Section D: Clinical perspectives in cancer nanomedicines 16. Formulation and biological stability of the nanomedicines in cancer treatment 17. Nanotoxicology profiling of cancer nanomedicines 18. Clinical translation status of nanoformulations
Section E: Regulatory perspectives in cancer nanomedicines 19. GLP and cGMP requirements in the development of cancer nanomedicines 20. Quality by Design approach for systematic development of nanopharmaceutical products